JP2005520624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005520624A5 JP2005520624A5 JP2003577758A JP2003577758A JP2005520624A5 JP 2005520624 A5 JP2005520624 A5 JP 2005520624A5 JP 2003577758 A JP2003577758 A JP 2003577758A JP 2003577758 A JP2003577758 A JP 2003577758A JP 2005520624 A5 JP2005520624 A5 JP 2005520624A5
- Authority
- JP
- Japan
- Prior art keywords
- animal
- antibiotic
- injection
- ceftiofur
- antibiotics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003115 biocidal Effects 0.000 claims 13
- 238000002347 injection Methods 0.000 claims 7
- 239000007924 injection Substances 0.000 claims 7
- ZBHXIWJRIFEVQY-IHMPYVIRSA-N Ceftiofur Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 ZBHXIWJRIFEVQY-IHMPYVIRSA-N 0.000 claims 6
- 239000003242 anti bacterial agent Substances 0.000 claims 6
- 229940064005 Antibiotic throat preparations Drugs 0.000 claims 5
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 claims 5
- 229940042052 Antibiotics for systemic use Drugs 0.000 claims 5
- 229940042786 Antitubercular Antibiotics Drugs 0.000 claims 5
- 229940093922 Gynecological Antibiotics Drugs 0.000 claims 5
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 claims 5
- 239000002253 acid Substances 0.000 claims 5
- 229960005229 ceftiofur Drugs 0.000 claims 5
- 229940079866 intestinal antibiotics Drugs 0.000 claims 5
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 claims 5
- 206010060945 Bacterial infection Diseases 0.000 claims 4
- 210000003625 Skull Anatomy 0.000 claims 3
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 claims 2
- 206010038683 Respiratory disease Diseases 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 229960003760 florfenicol Drugs 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000012053 oil suspension Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 230000000087 stabilizing Effects 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- SUQUWONDIBHQOZ-NWDGAFQWSA-N 1-cyclopropyl-6-fluoro-8-methoxy-7-[(3R)-3-[(1S)-1-(methylamino)ethyl]pyrrolidin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@H]([C@H](C)NC)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1OC SUQUWONDIBHQOZ-NWDGAFQWSA-N 0.000 claims 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 claims 1
- -1 2-amino-1,3-thiazol-4-yl Chemical group 0.000 claims 1
- 229960004920 Amoxicillin Trihydrate Drugs 0.000 claims 1
- 229960003311 Ampicillin Trihydrate Drugs 0.000 claims 1
- SPFYMRJSYKOXGV-UHFFFAOYSA-N BAY VP 2674 Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims 1
- BVGLIYRKPOITBQ-ANPZCEIESA-N Benzathine benzylpenicillin Chemical compound C=1C=CC=CC=1C[NH2+]CC[NH2+]CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 BVGLIYRKPOITBQ-ANPZCEIESA-N 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 229960001356 Ceftiofur hydrochloride Drugs 0.000 claims 1
- 229960004385 Danofloxacin Drugs 0.000 claims 1
- QMLVECGLEOSESV-RYUDHWBXSA-N Danofloxacin Chemical compound C([C@@H]1C[C@H]2CN1C)N2C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=CC=1N2C1CC1 QMLVECGLEOSESV-RYUDHWBXSA-N 0.000 claims 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 210000003205 Muscles Anatomy 0.000 claims 1
- 241000283898 Ovis Species 0.000 claims 1
- 229960000625 Oxytetracycline Drugs 0.000 claims 1
- 239000004100 Oxytetracycline Substances 0.000 claims 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims 1
- 229950002166 Premafloxacin Drugs 0.000 claims 1
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 claims 1
- 210000003079 Salivary Glands Anatomy 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- JTSDBFGMPLKDCD-XVFHVFLVSA-N TILMICOSIN Chemical compound O([C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CCN1C[C@H](C)C[C@H](C)C1)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O JTSDBFGMPLKDCD-XVFHVFLVSA-N 0.000 claims 1
- 229960004059 Tylosin Drugs 0.000 claims 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N Tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 claims 1
- 239000004182 Tylosin Substances 0.000 claims 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 1
- MQXQVCLAUDMCEF-CWLIKTDRSA-N amoxicillin trihydrate Chemical compound O.O.O.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 MQXQVCLAUDMCEF-CWLIKTDRSA-N 0.000 claims 1
- RXDALBZNGVATNY-CWLIKTDRSA-N ampicillin trihydrate Chemical compound O.O.O.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 RXDALBZNGVATNY-CWLIKTDRSA-N 0.000 claims 1
- 229960000740 enrofloxacin Drugs 0.000 claims 1
- 229960003276 erythromycin Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 235000019366 oxytetracycline Nutrition 0.000 claims 1
- 235000019371 penicillin G benzathine Nutrition 0.000 claims 1
- 230000000452 restraining Effects 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 229960000223 tilmicosin Drugs 0.000 claims 1
- 235000019375 tylosin Nutrition 0.000 claims 1
Claims (19)
- 非ヒト動物の耳介と頭蓋との接合部にて抗生物質を皮下注射する工程を含むことを特徴とする、それを必要とする該動物において細菌感染を治療または予防するのに有効な量の抗生物質を投与する方法。
- 該動物がウシ、ブタ、ヒツジおよびヤギよりなる群から選択される請求項1記載の方法。
- 該注射が該接合部の背後部側半分内である請求項2記載の方法。
- 該動物がウシから選択され、抗生物質を頸部耳介筋の後側であって耳下唾液腺の背後側に注射することを含む請求項2記載の方法。
- 抗生物質が処方されたものである請求項1記載の方法。
- 該処方が滅菌油懸濁液である請求項5記載の方法。
- 該処方の注射容量が約1mlないし約15mlである請求項6記載の方法。
- 該抗生物質が単一のシリンジ針で注射される請求項1記載の方法。
- 該抗生物質がプロカインペニシリン、ベンザチンペニシリン、セフチオフル結晶遊離酸、セフチオフル塩酸塩、アンピシリン三水和物、アモキシシリン三水和物、オキシテトラサイクリン、エリスロマイシン、タイロシン(tylosin)、ティルミコシン(tilmicosin)、フロルフェニコール(florfenicol)、エンロフロキサミン(enrofloxacin)、ダノフロキサシン(danofloxacin)、およびプレマフロキサシン(premafloxacin)よりなる群から選択される請求項1記載の方法。
- 該セフチオフル結晶遊離酸が滅菌油懸濁液におけるものである請求項10記載の方法。
- 細菌感染がウシ呼吸器系病またはブタ呼吸器系病である請求項11記載の方法。
- セフチオフル結晶遊離酸の量が約1.1ないし約8.8mg/kg体重である請求項12記載の方法。
- セフチオフル結晶遊離酸の量が約4.4ないし約6.6mg/kg体重である請求項13記載の方法。
- 非ヒト動物の耳介と頭蓋との接合部に液体形態の抗生物質を皮下注射する工程を含むことを特徴とする、それを必要とする該動物において細菌感染を治療または予防するのに有効な量の抗生物質を投与する方法。
- 該抗生物質が注射溶液または注射懸濁液の形態である請求項15記載の方法。
- 拘束メカニズムを使用することなく非ヒト動物の頭部を安定化させ;次いで、
該動物の耳介と頭蓋との接合部にて抗生物質を皮下注射する;
工程を含むことを特徴とする、それを必要とする該動物において細菌感染を治療または予防するのに有効な量の抗生物質を投与する方法。 - 該安定化工程が、該動物を倒し、次いで、手で該動物の注射部位の耳を握ることを含む請求項17記載の方法。
- 該抗生物質が注射溶液または注射懸濁液の形態である請求項17記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36621202P | 2002-03-21 | 2002-03-21 | |
PCT/US2003/008571 WO2003079923A1 (en) | 2002-03-21 | 2003-03-19 | Method of administering an injectable antibiotic to the ear of an animal |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005520624A JP2005520624A (ja) | 2005-07-14 |
JP2005520624A5 true JP2005520624A5 (ja) | 2006-05-11 |
JP4365222B2 JP4365222B2 (ja) | 2009-11-18 |
Family
ID=28454766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003577758A Expired - Lifetime JP4365222B2 (ja) | 2002-03-21 | 2003-03-19 | 注射用抗生物質を動物の耳に投与する方法 |
Country Status (15)
Country | Link |
---|---|
US (3) | US20030181398A1 (ja) |
EP (1) | EP1485040B2 (ja) |
JP (1) | JP4365222B2 (ja) |
KR (1) | KR20040097187A (ja) |
CN (1) | CN1635856A (ja) |
AT (1) | ATE343980T1 (ja) |
AU (1) | AU2003230697B2 (ja) |
BR (1) | BR0308523A (ja) |
CA (1) | CA2476327A1 (ja) |
DE (1) | DE60309447T3 (ja) |
ES (1) | ES2275092T5 (ja) |
IL (1) | IL164158A0 (ja) |
MX (1) | MXPA04009177A (ja) |
WO (1) | WO2003079923A1 (ja) |
ZA (1) | ZA200406501B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107982214B (zh) * | 2016-10-26 | 2021-02-05 | 华中农业大学 | 兽用恩诺沙星固体脂质纳米混悬液及其制备方法 |
BR112019013016B1 (pt) | 2016-12-23 | 2023-05-02 | Intervet International B.V. | Compostos antibacterianos, composição farmacêutica que os compreende e uso dos referidos compostos |
MX2019007350A (es) | 2016-12-23 | 2019-11-05 | Intervet Int Bv | Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina. |
CN107802613B (zh) * | 2017-11-13 | 2020-01-31 | 郑州大学 | 一种掩味肠道速释型替米考星微纳米干混悬剂及其制备方法 |
AU2019296380B2 (en) | 2018-06-25 | 2024-02-29 | Intervet International B.V. | Compounds for the treatment of bovine or swine respiratory disease |
US20210292284A1 (en) * | 2018-06-25 | 2021-09-23 | Intervet Inc. | Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni |
CN109077999A (zh) * | 2018-08-31 | 2018-12-25 | 田红卫 | 一种长效缓释替米考星注射液及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2883984A (en) * | 1957-09-09 | 1959-04-28 | Pfizer & Co C | Pellet implanter |
US2999020A (en) * | 1959-06-09 | 1961-09-05 | Hodges Res & Dev Co | Processes for the tendering of meat |
US4902683A (en) * | 1984-10-25 | 1990-02-20 | The Upjohn Company | Crystalline cephalosporin hydrohalide salts |
DE3869135D1 (de) * | 1987-07-29 | 1992-04-16 | Upjohn Co | Kontrollierte freisetzung von antibiotika-salzen aus einem implantat. |
ZA889601B (en) * | 1987-09-23 | 1989-10-25 | Petrus Burger Andries | A composition for use in treating animals |
US5258528A (en) * | 1990-11-30 | 1993-11-02 | Warner-Lambert Company | Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group |
AU694419B2 (en) † | 1993-03-12 | 1998-07-23 | Zoetis P&U Llc | Crystalline ceftiofur free acid |
US6074657A (en) * | 1997-03-20 | 2000-06-13 | Pharmacia & Upjohn Company | Administration of an injectable antibiotic in the ear of an animal |
-
2003
- 2003-03-19 AU AU2003230697A patent/AU2003230697B2/en not_active Expired
- 2003-03-19 MX MXPA04009177A patent/MXPA04009177A/es active IP Right Grant
- 2003-03-19 AT AT03723787T patent/ATE343980T1/de not_active IP Right Cessation
- 2003-03-19 CN CNA038042940A patent/CN1635856A/zh active Pending
- 2003-03-19 KR KR10-2004-7014785A patent/KR20040097187A/ko not_active Application Discontinuation
- 2003-03-19 DE DE60309447.3T patent/DE60309447T3/de not_active Expired - Lifetime
- 2003-03-19 BR BR0308523-6A patent/BR0308523A/pt not_active Application Discontinuation
- 2003-03-19 US US10/391,676 patent/US20030181398A1/en not_active Abandoned
- 2003-03-19 EP EP03723787.2A patent/EP1485040B2/en not_active Expired - Lifetime
- 2003-03-19 CA CA002476327A patent/CA2476327A1/en not_active Abandoned
- 2003-03-19 JP JP2003577758A patent/JP4365222B2/ja not_active Expired - Lifetime
- 2003-03-19 IL IL16415803A patent/IL164158A0/xx unknown
- 2003-03-19 WO PCT/US2003/008571 patent/WO2003079923A1/en active IP Right Grant
- 2003-03-19 ES ES03723787T patent/ES2275092T5/es not_active Expired - Lifetime
-
2004
- 2004-08-16 ZA ZA200406501A patent/ZA200406501B/en unknown
-
2010
- 2010-10-27 US US12/912,942 patent/US8968759B2/en not_active Expired - Lifetime
-
2015
- 2015-01-22 US US14/603,024 patent/US20150182454A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6074657A (en) | Administration of an injectable antibiotic in the ear of an animal | |
Prescott | Beta‐lactam antibiotics: penam penicillins | |
US20070141086A1 (en) | Use of antibiotics as vaccine adjuvants | |
US20150182454A1 (en) | Method of administering an injectable antibiotic to an animal | |
JP2005520624A5 (ja) | ||
Constable et al. | Guidelines for antimicrobial use in cattle | |
JP2013542226A5 (ja) | ||
JP2004501973A (ja) | 乳房炎の治療および予防のための方法 | |
CA2417843A1 (en) | Administration of an injectable antibiotic in the ear of an animal | |
Stetsko et al. | Clinical study therapeutic efficacy danoksan 50 pigs the treatment klebsiyelozu | |
Taboada et al. | New drugs, new approaches for antimicrobial therapy. |